Vanguard Global Advisers’s CryoPort CYRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$389K Buy
24,747
+3,796
+18% +$48.7K ﹤0.01% 2215
2026
Q1
$173K Buy
+20,951
New +$189K ﹤0.01% 2502

Other funds holding CYRX

Vanguard Global Advisers's CYRX Position: Q2 2026 in Review

Vanguard Global Advisers increased its CryoPort (CYRX) stake by 18% in Q2 2026, buying an estimated $48.7K and bringing the position to 24,747 shares worth $389K. The position accounts for ﹤0.01% of the portfolio, ranked #2215.

Vanguard Global Advisers first reported a position in CYRX in Q1 2026 and has held it in 2 quarters since. 184 funds tracked by Wall St. Rank hold CYRX as of Q2 2026.

  • Vanguard Global Advisers held 24,747 shares of CryoPort worth $389K as of Q2 2026.
  • Vanguard Global Advisers bought 3,796 CryoPort shares in Q2 2026, an estimated $48.7K.
  • CryoPort made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2215 holding.
  • Vanguard Global Advisers first reported a position in CryoPort in Q1 2026 and has held it in 2 quarters since.
  • 184 funds tracked by Wall St. Rank held CryoPort as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.